T-DXd yang digabungkan dengan Sotorasib menunjukkan keberkesanan yang menjanjikan dalam kajian praklinikal kanser paru-paru bukan sel kecil mutan KRAS G12C – Oncodaily
T-DXd yang digabungkan dengan Sotorasib menunjukkan keberkesanan yang menjanjikan dalam kajian praklinikal kanser paru-paru bukan sel kecil mutan KRAS G12C.
Kandungan penuh artikel
T-DXd Plus Sotorasib in KRAS G12C-Mutant NSCLC showed durable preclinical tumor regressions and highlighted HER2 testing gaps. , ADCs, Antibody drug conjugates, HER2, HER2 expression, HER2 IHC, KRAS G12C, KRAS G12C-mutant NSCLC, KRAS inhibitor resistance, Lung cancer, NSCLC, OncoDaily Lung, Precision Oncology, preclinical oncology, Sotorasib, T-Dxd, targeted therapy, Thoracic Oncology, Trastuzumab deruxtecan, xenograft models
Produk Berkaitan Artikel Ini
Produk ini dipadankan secara automatik berdasarkan tajuk, ringkasan, dan kandungan artikel.
Soalan Lazim
Which products are related to this article?
The system matched these relevant products from the article content: Lucius Sotorasib – Beli dalam talian SOTOLDX Sotorasib 120mg.
How can I view the medicines discussed in this article?
Use the related product cards below the article to review available specifications, prices, product information, and reviews.
Does this article replace advice from a doctor or pharmacist?
No. This content is for general information and health education only. Follow the prescription and individual guidance provided by qualified healthcare professionals.